RLMD·75955J402·US·equity·Healthcare - Biotechnology-13D/G
RLMD (RELMADA THERAPEUTICS INC) is held by 47 institutional investors as of Q4 2025. Largest holders: JANUS HENDERSON GROUP PLC ($35M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($20.6M), MARSHALL WACE, LLP ($15.4M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer